Olmesartan Medoxomil And Hydrochlorothiazide Tablet
Product Images NDC 43547-392

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Olmesartan Medoxomil And Hydrochlorothiazide (NDC 43547-392). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Solco Healthcare Us, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure, Olmesartan Medoxomil (Spl Image1 Structure1)

FDA Label Image

Structure, Hydrochlorothiazide (Spl Image2 Structure2)

FDA Label Image

Container Label 20 mg/12.5 mg 90 Tablets (Spl Image3 Label1 20mg)

This appears to be a medication label containing information on Olmesartan Medoxomil and Hydrochlorothiazide tablets with a dosage of 20/12.5 mg, manufactured by Sandoz, LLC.*

FDA Label Image

Container Label 40 mg/12.5 mg 90 Tablets (Spl Image4 Label2 40mg 12 5mg)

This text describes a medication in tablet form that contains two active ingredients: olmesartan medoxomil (40mg) and hydrachlorothiazide (125mg). The dosage and use instructions are not provided and readers are directed to refer to the package insert. The medication should be stored within a specific temperature range and is manufactured by Zhejiang Huahai Pharmaceutical Co. Ltd in China. It is distributed by Solco Healthcare in the USA. The revision date for the information provided in the text is February 2017.*

FDA Label Image

Container Label 40 mg/25 mg 90 Tablets (Spl Image5 Label3 40mg 25mg)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.